Evaluation of the Efficacy and Safety of DM05 Versus Optive™ on the Treatment of Moderate to Severe Ocular Dryness

NACompletedINTERVENTIONAL
Enrollment

80

Participants

Timeline

Start Date

December 1, 2016

Primary Completion Date

January 2, 2018

Study Completion Date

March 30, 2018

Conditions
Dry Eye
Interventions
DEVICE

DM05 eye drops

Ophthalmic use. One to two drops instilled in each eye from 4 to 6 times per day during 84 days of treatment.

DEVICE

Optive™ eye drops

Ophthalmic use. One to two drops instilled in each eye from 4 to 6 times per day during 84 days of treatment.

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Horus Pharma

INDUSTRY